Nystatin Articles
Warner Chilcott files low-dose OC NDA
30 March 2009
Vit D supps "reduce fracture risk up to 20%"
30 March 2009
Gilead begins enrolling into Ph II trial of cicletanine
30 March 2009
Santhera highlights new cachexia data
30 March 2009
Tibotec fully enrolled for HIV trial
30 March 2009
OSI submits Tarceva in Europe and USA
30 March 2009
Genzyme's Renvela gets nod for expanded EU label
30 March 2009
ProStrakan's 2008 revenue up 23%
30 March 2009
Biogen's PD drug passes Ph II testing
27 March 2009
TauTaTis' lead compound "could work in PD as well as AD"
23 March 2009
S-P's TRA meets Ph II study endpoints
23 March 2009
US FDA approves Orexo's Edluar
23 March 2009
Japan stock market week to March 16, 2009
23 March 2009
Nordisk's liraglutide reduces HbA1c
23 March 2009
Teikoku to help Eisai develop donepezil skin patch
16 March 2009
WHO indentifies new research priorities
16 March 2009
Oral-lyn trial on track for successful early finish
16 March 2009
Japan stock market week to Mar 9, 2009
16 March 2009
Basilea's Toctino cleared by SMC
16 March 2009
NICE gives nod to Bayer's Xarelto
16 March 2009
WHO indentifies new research priorities
16 March 2009
Endo set to return rights to painkiller skin patch
16 March 2009
Lee's Pharma in deal with Nippon Shinyaku
16 March 2009
Takeda's alogliptin NDA subject to new guidance
16 March 2009
GSK submits EMEA MAA for pazopanib in RCC
9 March 2009
Early data show clinical activity for phenoxodiol
9 March 2009
Promising initial Ph II data on Ascenta's AT-101
9 March 2009
FDA orders boxed warning on metaclopramide
9 March 2009
Four Novartis drugs and B-MS
9 March 2009
Prulifloxacin stops diarrhea in under 2 days
9 March 2009
Genzyme to move Gaucher drug to Ph III
2 March 2009
Japan stock market week to Feb 23, 2009
2 March 2009
Bayer cleared to begin UK trials of riociguat
23 February 2009
Abbott and Enanta to begin Ph I HCV trial
23 February 2009
EU orphan status for arGentis' ARG201
23 February 2009
Takeda/Teijin gain US OK for new gout drug
23 February 2009
Amarillo hep C agent cleared for Ph II in Taiwan
23 February 2009
Bayer takes riociguat into Phase III
16 February 2009
Adeona gets Japanese patent for RA therapy
16 February 2009
Taro's generic levetiracetam cleared by US FDA
16 February 2009
TorreyPInes' Ph I pain candidate safe in trials
16 February 2009
Japan stock market week to Feb 9, 2009
16 February 2009
Janssen PE drug gets OK in Finland and Sweden
16 February 2009
Roxro's intranasal ketorolac accepted for review
16 February 2009
ProStrakan signs two Sancuso marketing deals
16 February 2009
S-P completes patient enrollment in Ph III boceprevir study
9 February 2009
Gates Foundation pledges $25M to Nigerian Polio vaccination
9 February 2009
Transition fully enrolled for gastrin analog trial
9 February 2009
Stock Commentary - Europe - week to Feb 2, 2009
9 February 2009
First generic for common STD from BioComp
9 February 2009
Rexahn initiates Ph IIa MDD study of Serdaxin
9 February 2009
Mochida seeks OTC switch for Epadel
9 February 2009
NICE in cost-sharing deal for MM drug
9 February 2009
Myriad buys Panacos' bevirimat for $7M
26 January 2009
Celldex licenses CholeraGarde and ETEC to Vaccine Technologies
26 January 2009
FDA warns over use of topical anesthetics
26 January 2009
UK pre-school children taking unnecessary steroid
26 January 2009
Ariad updates investors on portfolio
26 January 2009
Leptin sensitizers lead to weight loss in mice
26 January 2009
Cypress gains FDA approval for generic Keppra
26 January 2009
Long-term lack of stability at US FDA
26 January 2009
FDA delays decision on Takeda's febuxostat
26 January 2009
Zolinza/Velcade combo enters Ph IIb MM trial
26 January 2009
Emergency listing of HIV drugs in Japan
26 January 2009
Roxane's generic Keppra cleared in USA
26 January 2009
Roche GI cancer therapy as good as FOLFOX
26 January 2009
Immuron's HIV antibody goes into US trail
19 January 2009
Strong in vivo data on Ablynx' antiviral Nanobody
19 January 2009
Genta begins trials for novel oral taxane
19 January 2009
Generex' insulin mouth spray approved in Lebanon
19 January 2009
Japan stock market week to Jan 12, 2009
19 January 2009
Ovation's Sabril recommended for epilepsy
19 January 2009
Lexicon initiates Ph II IBS trial for LX1031
19 January 2009
Roche in up to $335M deal with Plexxikon
19 January 2009
CHMP OKs Actelion's Zavesca for NPC
15 January 2009
King divests drug to clear Alpharma merger
12 January 2009
Japan stock market week to Jan 5, 2009
12 January 2009
Amira's DP2 blocker on track for US IND in mid-2009
12 January 2009
Galapagos revives dropped cachexia drug
12 January 2009
FDA calls in experts for prasugrel review
12 January 2009
DOR gets FDA go ahead for pivotal orBec trial
12 January 2009
Labopharm's once-daily Ryzolt cleared by FDA
12 January 2009
Warner Chilcott and Barr settle Femcon dispute
12 January 2009
Antisoma's CLL tablet approved by US FDA
12 January 2009
Santarus licenses two Cosmo MMX drugs for USA
12 January 2009
Tibotec recruiting for two Ph III trials of NNRTI
12 January 2009
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
